ライフサイエンスコーパス: technetium

1 ed with the blue dye and 65 (94.2%) with the technetium.

2 exes and their higher homologues rhenium and technetium.

3 ed the first human study of [99mTc]TRODAT-1, technetium, 2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabi

4 ration of 740 MBq (20 mCi) [99mTc]-TRODAT-1 (technetium, [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azab

5 [99mTc]Technetium[2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabic

6 erwent blinded research core laboratory (99m)technetium-3,3-diphosphono-1,2-propanodicarboxylic acid

7 ntravenous injection of 30 mCi (1110 MBq) of technetium 99 ((99m)Tc)-sestamibi and were imaged in cra

8 ess echocardiography (DASE) and dipyridamole Technetium 99-m (Tc-99m) sestamibi single photon emissio

9 The effective removal of radioactive technetium ((99)Tc) from contaminated water is of enormo

10 Technetium ((99)Tc) is a problematic fission product for

11 Technetium ((99)Tc) is an abundant, long-lived radioacti

12 Technetium-99 ((99)Tc) (beta(-)(max): 293.7 keV; t(1/2):

13 Treatment and immobilization of technetium-99 ((99)Tc) contained in reprocessed nuclear

14 The immobilization of technetium-99 ((99)Tc) in a suitable host matrix has pro

15 f radionuclides with long half-lives such as technetium-99 ((99)Tc), uranium-238 ((238)U), and iodine

16 Technetium-99 (Tc) is an important radionuclide of conce

17 to generate solid waste forms (e.g., glass), technetium-99 (Tc) is of concern because of its volatili

18 Technetium-99 (Tc), a high yield fission product generat

19 A preconcentrating minicolumn sensor for technetium-99 detection in water consists of a packed be

20 Technetium-99 immobilization in low-temperature nuclear

21 concentration and scintillation detection of technetium-99 in water.

22 ansthyretin cardiac amyloidosis referred for technetium-99 m pyrophosphate at a single tertiary cente

23 An efficient 1-hour technetium-99 m pyrophosphate protocol had comparable di

24 Technetium-99 m pyrophosphate protocols for transthyreti

25 (n=242) were compared with subsequent SPECT Technetium-99 m Sestamibi, measuring the percentage of t

26 Patients were injected with 1.0 mCi of technetium-99 sulfur colloid (unfiltered) in the subareo

27 ater at contaminated nuclear facilities with technetium-99, one of the most mobile radionuclides enco

28 Traditional tracers included technetium 99m ( 99m Tc) sulfur colloid, gallium 67, and

29 e, microsphere blood flow (MBF) testing, and technetium 99m ((99m)Tc) 2 methoxyisobutylisonitrile (MI

30 Tumor-absorbed dose was computed using technetium 99m ((99m)Tc) macroaggregated human albumin (

31 determine if commonly administered doses of technetium 99m ((99m)Tc) mertiatide (MAG3) in the range

32 ), which promotes in vivo cellular uptake of technetium 99m ((99m)Tc) or iodine 124 ((124)I), as a re

33 sm who underwent preoperative imaging with a technetium 99m ((99m)Tc) sestamibi and (99m)TcO4- protoc

34 nclusive results at ultrasonography (US) and technetium 99m ((99m)Tc) sestamibi scintigraphy.

35 on emission computed tomography (SPECT) with technetium 99m ((99m)Tc) tropane dopamine transporter (T

36 maged owing to internally bound, or trapped, technetium 99m ((99m)Tc)-labeled hSSTr2-binding peptide

37 between the lung elimination rate of inhaled technetium 99m ((99m)Tc)-sestamibi and immunohistochemic

38 iated HIV surrogate) and 18.5-MBq (500-muCi) technetium 99m ((99m)Tc)-sulfur colloid (HIV-sized 100-n

39 e kidney MR GFR indices correlated well with technetium 99m (99mTc) diethylenetriaminepentaacetic aci

40 In vitro binding assays of technetium 99m (99mTc)-labeled Cy7 tilmanocept were cond

41 7-labeled egg and intravenously administered technetium 99m diisopropyl-imino-diacetic acid were imag

42 In vivo localization of technetium 99m hydrazinonicotinamide-annexin V was teste

43 Technetium 99m hydroxymethane diphosphonate SPECT/CT bon

44 er tumor radiation-absorbed dose computed at technetium 99m macroaggregated human albumin SPECT/CT wa

45 After intravenous application of 75 MBq of technetium 99m pertechnetate, freehand three-dimensional

46 In single-center studies, technetium 99m pyrophosphate (Tc 99m PYP) cardiac imagin

47 inologist (S.J.M.), who decided to perform a technetium 99m sestamibi ((99m)Tc MIBI) parathyroid scan

48 y and gamma imaging after a 740-mBq (20-mCi) technetium 99m sestamibi injection.

49 cy compared with that of ultrasonography and technetium 99m sestamibi scanning may be sufficient to a

50 A drawn dose of 8 mCi (296 MBq) of technetium 99m sestamibi was administered to all patient

51 r injection with 25-30 mCi (925-1110 MBq) of technetium 99m sestamibi, patients were imaged with a hi

52 zation of sentinel lymph nodes with filtered technetium 99m sulfur colloid.

53 9 ((129)Xe) MRI (hereafter, (129)Xe MRI) and technetium 99m-diethylenetriaminepentaacetic acid aeroso

54 elates with hyperpolarized xenon 129 MRI and technetium 99m-diethylenetriaminepentaacetic acid aeroso

55 ratively, and 1 year later, ultrasonography, technetium 99m-dimercaptosuccinic acid (DMSA) scintigrap

56 structured psychiatric interview and resting technetium 99m-hexamethyl-propyleneamine oxime single ph

57 ctice CD16 CliniMACS isolation, labeled with technetium 99m-hexamethylpropyleneamine oxime, and then

58 uthors' goal was to evaluate the accuracy of Technetium 99m-HMPAO-labeled leukocyte imaging for scree

59 gnostic performance of parathyroid 4D CT and technetium 99m-sestamibi (hereafter, referred to as sest

60 ommended dose of 740-1100 MBq (20-30 mCi) of technetium 99m-sestamibi is estimated to involve an LAR

61 gregates of human serum albumin labeled with technetium 99m.

62 icotinamide, annexin V was radiolabeled with technetium 99m.

63 ients with suspected CAD who underwent CCTA, technetium 99m/tetrofosmin-labeled SPECT, and [15O]H2O P

64 We performed intraoperative technetium-99m ((99m)Tc) sentinel lymph node (SN) mappin

65 was to determine the extent to which inhaled technetium-99m ((99m)Tc)-labeled carbon nanoparticles (T

66 on, for targeting human CRC xenografts using technetium-99m ((99m)Tc)-labeled TCP-1 and fluorescent c

67 r myocardial perfusion imaging of mice using technetium-99m ((99m)Tc)-sestamibi and demonstrate the f

68 imaging and to determine whether dobutamine technetium-99m ((99m)Tc)-sestamibi single-photon emissio

69 labeled with indium-111 ((111)In)-oxine and technetium-99m ((99m)Tc)-Ultratag or (99m)Tc-Ceretec.

70 affinity for apoptotic cells in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent t

71 3) chelator has been shown to stably complex technetium-99m (99mTc) for nuclear imaging and radiorhen

72 ulty, we have studied a radiopharmaceutical, technetium-99m (99mTc) Infecton, which is based on the a

73 ne (MAG3) forms a single stable chelate with technetium-99m (99mTc) oxotechnetate.

74 ke of thallium-201 (201Tl) at rest with rest technetium-99m (99mTc) sestamibi uptake in the same pati

75 Technetium-99m (99mTc)-labeled leukocytes were quantifie

76 ed tomography (SPECT) after the injection of technetium-99m (Tc-99m) sestamibi at rest.

77 LV) function and infarct size as assessed by technetium-99m (Tc-99m) sestamibi perfusion tomographic

78 e addition of electrocardiographically gated technetium-99m (Tc-99m) sestamibi single-photon emission

79 Technetium-99m (Tc-99m) sestamibi was injected before re

80 We compared dipyridamole technetium-99m (Tc-99m) tetrofosmin and thallium-201 (Tl

81 clinical use and cost-analysis of acute rest technetium-99m (Tc-99m) tetrofosmin single-photon emissi

82 photon emission computed tomographic (SPECT) technetium-99m (Tc-99m) tracer imaging in patients with

83 r repairs that led to a critical shortage of technetium-99m (Tc-99m).

84 Our objective is to prove that injection of technetium-99m (Tc99) sulfur colloid in a subareolar man

85 Technetium-99m activity was monitored with a Nal probe.

86 hese defects were compared with risk area on technetium-99m autoradiography and infarct size on tissu

87 r short-axis slices of equal thickness using technetium-99m autoradiography and tissue staining, resp

88 ith human recombinant annexin V labeled with technetium-99m before imaging.

89 Twenty healthy volunteers underwent technetium-99m bicisate SPECT under baseline conditions

90 ulted in the formation of '3+1' mixed-ligand technetium-99m complexes [TcO(SN(R)S)(SNX(2))] in high r

91 These results suggest that small technetium-99m complexes could be useful as potential me

92 The number of lymph nodes removed, technetium-99m counts for each sentinel lymph node, pres

93 territory caused significant acceleration of technetium-99m diethylenetriamine pentaacetic acid (Tc-9

94 ade it the radiotracer of choice compared to technetium-99m diethylenetriamine pentaacetic acid (Tc-9

95 Simultaneous renal scans (technetium-99m diethylenetriamine pentaacetic acid) of t

96 aphy scans for MIBG-nonavid disease, replace technetium-99m diphosphonate bone scintigraphy for osteo

97 xenon-133 in 261 patients and with injected technetium-99m hexamethyl-propyleneamine oxime (HMPAO) i

98 Radiolabeling with technetium-99m in aqueous media was efficient and gave r

99 ction of apoptosis, such as that achieved by technetium-99m labeled Annexin-A5 scintigraphy.

100 he 41 mice, 6, 6, and 5 received intravenous technetium-99m labeled CRIP for micro-single-photon emis

101 stress and time control were estimated using technetium-99m labelled autologous red blood cells and g

102 were determined by gamma camera imaging with technetium-99m labelled erythrocytes.

103 The better quality of images obtained with technetium-99m mercaptoacetyltriglycine (Tc-99m MAG3) ha

104 Within 2 hours of US, technetium-99m pertechnetate was intravenously administe

105 m, collected via apheresis, and labeled with technetium-99m radioisotope for single-photon emission c

106 mine transporter levels were measured with a technetium-99m radiolabeled analog of cocaine, TRODAT-1,

107 gh specificity of SPECT/CT examination using technetium-99m radiolabeled red blood cells (Tc-99m-RBC)

108 m-enhanced inversion-recovery MR imaging and technetium-99m renal cortical scintigraphy.

109 Parathyroid imaging using technetium-99m sestamibi (MIBI) has evolved and can loca

110 rfusion imaging with thallium-201 (n=173) or technetium-99m sestamibi (n=72) and either dipyridamole

111 The technique involved injecting 20 mCi technetium-99m sestamibi 2 hours before surgery and perf

112 s suggest that early perfusion imaging using technetium-99m sestamibi enables reliable risk stratific

113 t ventricular (LV) function from post-stress technetium-99m sestamibi gated SPECT performed >15 min a

114 ts who underwent rest thallium-201/adenosine technetium-99m sestamibi MPS, 254 (4.1%) were lost to fo

115 wall thickening from three-dimensional gated technetium-99m sestamibi myocardial perfusion single-pho

116 assess the diagnostic efficacy of adenosine technetium-99m sestamibi myocardial perfusion single-pho

117 easurement of infarct size by serum markers, technetium-99m sestamibi single-photon emission computed

118 cise variables of rest thallium-201/exercise technetium-99m sestamibi single-photon emission computed

119 cardiac magnetic resonance (CMR) imaging or technetium-99m sestamibi single-photon emission computed

120 either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed

121 ribution thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging.

122 Infarct size, measured by CMR or technetium-99m sestamibi SPECT within 1 month after prim

123 the ability of early perfusion imaging using technetium-99m sestamibi to predict adverse cardiac outc

124 was measured in a subset of 243 patients by technetium-99m sestamibi tomography.

125 Technetium-99m sestamibi uptake after injection at rest

126 Technetium-99m sestamibi was injected 3 min after the co

127 erfusion images using either thallium-201 or technetium-99m sestamibi, and no previous coronary revas

128 est pain underwent MP imaging with SPECT and technetium-99m sestamibi.

129 and after 300 mL of Ensure was measured with technetium-99m single-photon emission computed tomograph

130 review of studies where either Rb-82 PET or technetium-99m SPECT with both attenuation correction an

131 technique involved the injection of 4 ml of technetium-99m sulfur colloid (1 mCi [37 MBq]) into the

132 exercise (44%) or pharmacologic stress (56%) technetium-99m tetrofosmin SPECT.

133 Technetium-99m TRODAT-1 is an analog of cocaine that sel

134 Complexation of technetium-99m with a mixture of N-R(3-azapentane-1,5-di

135 to 58) for a dual-isotope (thallium-201 plus technetium-99m) scan.

136 methodology for determining the transport of technetium-99m, a gamma-emitting metastable isomer of (9

137 nanobodies were generated, radiolabeled with technetium-99m, and screened in vitro on mouse and human

138 autologous PBMCs were isolated, labeled with technetium-99m, and visualized 3, 4.5, and 6 h post-infu

139 inoembryonic antigen (CEA) Fab' labeled with technetium-99m, in the presurgical evaluation of patient

140 Technetium-99m, the most commonly used radionuclide in n

141 od cells (RBCs), labeled with chromium-51 or technetium-99m, were separately coated to equal levels w

142 Technetium-99m-antimony trisulfide colloid was the radio

143 mor/nontumor ratios indicate that such small technetium-99m-based molecular probes can be developed a

144 Technetium-99m-bicisate/SPECT was compared prospectively

145 synthesized for incorporating the well-known technetium-99m-binding hydrazinonicotinamide ligand into

146 Technetium-99m-DD and 99mTc-LL-EC were excreted more rap

147 Technetium-99m-DD-EC had the highest clearance and extra

148 Technetium-99m-DD-EC has excellent imaging properties an

149 Technetium-99m-disofenin is a suitable label for solidph

150 Technetium-99m-disofenin labeling resulted in in vitro p

151 Technetium-99m-DTPA aerosol clearance measurements can b

152 Technetium-99m-DTPA distributed uniformly without signif

153 Technetium-99m-ECD SPECT and 18F-FDG PET showed regional

154 Technetium-99m-HMPAO and 99mTc-MIBI brain SPECT, MRI, CT

155 Technetium-99m-HMPAO ROI data also were expressed in uni

156 Technetium-99m-HSA demonstrated faster washout rates fro

157 Technetium-99m-L,L-ethylenedicysteine (99mTc-LL-EC) is a

158 maging of metastatic melanoma has shown that technetium-99m-labeled AADT-(CH2)2-NEt2 (99mTc-1) has th

159 the deposition and clearance of an ultrafine technetium-99m-labeled aerosol in 10 patients with chron

160 Technetium-99m-labeled annexin-V, an endogenous protein

161 tivity in experimental atherosclerosis using technetium-99m-labeled broad matrix metalloproteinase in

162 ocyte accumulation was assessed by uptake of technetium-99m-labeled chemotactic peptide (fMLFK) and c

163 the results of experiments with intravenous technetium-99m-labeled deimmunized antifibrin Fab' fragm

164 Serial technetium-99m-labeled dimercaptosuccinic acid ((99m)Tc-

165 urinary tract infection; renal scanning with technetium-99m-labeled dimercaptosuccinic acid has also

166 hrombi (DVTs) were formed in five dogs, then technetium-99m-labeled Fab' ( approximately 400 mg, appr

167 Technetium-99m-labeled matrix metalloproteinase inhibito

168 computed tomographic imaging, using RP805, a technetium-99m-labeled MMP-specific tracer, followed by

169 hma (FEV1, 76.8 +/- 11.4% predicted) inhaled technetium-99m-labeled monodisperse albuterol aerosols (

170 Technetium-99m-labeled nitroimidazole was administered t

171 Technetium-99m-labeled peptides and monoclonal antibody

172 Technetium-99m-labeled polydiethylenetriamine pentaaceti

173 It was used to synthesize a technetium-99m-labeled salmon calcitonin with the hynic-

174 iagnostic efficacy of flurpiridaz PET versus technetium-99m-labeled single photon emission computed t

175 Technetium-99m-liposome images showed prominent blood-po

176 Technetium-99m-MDP uptake in primary breast carcinoma ha

177 A technetium-99m-mebrofenin scan showed a photopenic area

178 Technetium-99m-N-NOET bound to RBCs was subsequently ext

179 Technetium-99m-N-NOET has high binding affinity to blood

180 Technetium-99m-N-NOET is a new 99mTc-labeled, neutral ca

181 Technetium-99m-N-NOET myocardial uptake (%ID) was signif

182 Technetium-99m-P483H also outperformed all controls, inc

183 Technetium-99m-P748 was prepared by either a ligand exch

184 Technetium-99m-P748 was readily prepared at room tempera

185 gen (CEA) Fab antibody fragment labeled with technetium-99m-pertechnetate (99mTc), was injected intra

186 Technetium-99m-Q57, 99mTc-Q58 and 99mTc-Q63 are avid tra

187 Technetium-99m-red blood cell (RBC) scintigraphy was und

188 Technetium-99m-sestamibi activity in the ischemic zone (

189 Technetium-99m-sestamibi appears to indicate the extent

190 Technetium-99m-sestamibi has recently been validated as

191 size with cardiac marker release patterns or technetium-99m-sestamibi single-photon emission computed

192 Technetium-99m-sestamibi was injected intravenously at p

193 SLN mapping requires injection of technetium-99m-sulfur colloid-an effective but sometimes

194 Technetium-99m-teboroxime clearance is markedly accelera

195 -)-N2,N2',S2,S2'] oxo-[1R-(exo-exo)]- [99mTc]technetium,[99mTc]TRODAT-1 (13), displayed the highest i

196 Andersen cascade validation data showed that technetium and albuterol were coassociated on each impac

197 Automated extraction (TEVA for technetium and UTEVA for uranium) and anion exchange (AG

198 ed from the actinides via valence control of technetium (as Tc(VII)) in a ferric hydroxide coprecipit

199 n the context of the long-term management of technetium at legacy nuclear sites.

200 Finally, subareolar injection of technetium avoids the problem of overlap of the radioact

201 ed to include not only thallium-201 but also technetium-based imaging agents such as sestamibi and te

202 A recent Technetium-based lymph node mapping study has provided s

203 imaging of the dopamine transporter using a technetium-based tropane analogue.

204 nonhuman primates of second-generation (99m)technetium-based tropane ligands that bind potently and

205 psilon-(Hynic-Boc)-Lys is a highly versatile technetium-binding amino acid for incorporation into pep

206 Alkaline phosphatase and technetium bone scan were sensitive ways of detecting ea

207 and its rhenium complex (and by analogy its technetium complex).

208 ctive rhenium as a surrogate for radioactive technetium complex.

209 VP (AVP(an)) have been synthesized using the technetium complexes with tetradentate tripodal chelator

210 ioactive metal-based complexes of copper and technetium designed as diagnostic imaging agents to dete

211 In the solid state, technetium dichloride exhibits a new structure type cons

212 Technetium dichloride has been discovered.

213 a magnetic susceptibility measurement shows technetium dichloride to be diamagnetic.

214 A second polymorph of technetium dichloride, beta-TcCl2, has been synthesized

215 and Normosol-R contained 500 microCi of (99m)technetium-diethylene triamine pentaacetic acid.

216 l was radiolabeled with 500 micro Ci of (99m)Technetium-diethylene triaminepentaacetic acid, and 10 m

217 predicted renal parenchymal disease on (99m)Technetium-dimercaptosuccinic acid ((99m)Tc-DMSA) scinti

218 ction differences (SFD) were quantified with technetium-dimercaptosuccinic acid renography.

219 Crystalline technetium dioxide was prepared and for the first time i

220 The volatility of technetium during sample ashing and solution evaporation

221 Vagal motor function was assessed by a technetium gastric emptying scan and a questionnaire to

222 estigate NI, assessed by extravasation of 99-Technetium-gluceptate (99Tc-G), as well as the role of m

223 After baseline (99m)technetium-hexa-methyl-propylene-amine-oxime scan, 1-T m

224 The PMCD method was evaluated with data from technetium human albumin macroaggregates ((99m)Tc-MAA) e

225 in in vitro and in vivo, two novel phosphine technetium(III) complexes were designed and characterize

226 The use of technetium imaging agents has recently been enhanced by

227 ddition of myocardial imaging agents such as technetium improves the sensitivity and specificity but

228 Chemical yields of technetium in entire procedure range from 60% to 95% dep

229 218 space group) with rhenium and technetium in the 7+ oxidation state.

230 Chemical yields of technetium in the overall procedure range from 60% to 75

231 Technetium incorporation into magnetite and its behavior

232 We report the incorporation of technetium into a family of synthetic spinel ferrites th

233 Technetium is a problematic contaminant at nuclear sites

234 s study suggest that subareolar injection of technetium is as accurate as peritumoral injection of bl

235 Technetium is injected subareolarly for localization of

236 Ru that is explained by the in situ decay of technetium isotope 99Tc in the grains.

237 It has long been recognized that technetium-labeled bone scintigraphy tracers can localiz

238 Technetium-labeled cardiac scintigraphy (i.e., Tc-PYP sc

239 lines clinical scenarios wherein findings on technetium-labeled cardiac scintigraphy have been misint

240 A technetium-labeled intravascular radiotracer was injecte

241 gated hyperbilirubinemia, failure to excrete technetium-labeled mebrofenin from the liver into the sm

242 or that purpose with a single injection of a technetium-labeled perfusion tracer.

243 n the past decade such as the development of technetium-labeled perfusion tracers and portable compac

244 ing techniques as well as the development of technetium-labeled perfusion tracers now permit combined

245 ries can be detected on SPECT images using a technetium-labeled radiotracer that targets apoptosis.

246 ons of blue dye alone or in combination with technetium-labeled sulfur colloid.

247 were performed using isosulfan blue dye and technetium-labeled sulfur colloid.

248 eight surgeons, using isosulfan blue dye and technetium-labeled sulfur colloid.

249 a combination of vital blue dye and filtered technetium-labeled sulfur colloid.

250 combination of a vital blue dye and filtered technetium-labeled sulfur colloid.

251 There are important differences between technetium-labeled tracers and thallium-201.

252 cardial perfusion studies are performed with technetium-labeled tracers in the United States.

253 important to review the prognostic value of technetium-labeled tracers.

254 ite similar baseline PaO(2), brain uptake of technetium macroaggregated albumin ((99m)TcMAA), or meas

255 Technetium mainly forms during artificial nuclear fissio

256 d and had defects in emptying, based on (99m)technetium-mebrofenin scintigraphy or post-prandial vari

257 In this study, technetium-mercaptoacetyltriglycine (MAG3) diuretic scin

258 lear and important implications for limiting technetium migration under conditions where magnetite is

259 Chromatographic behaviors of technetium, molybdenum, and ruthenium were investigated,

260 developed for simultaneous determination of technetium, neptunium, plutonium, and uranium in large v

261 To date published work on technetium NHC chemistry has been restricted to the oxid

262 Furthermore, the chemistry of technetium NHC compounds and their chemical behaviour ar

263 ve, analogues of the potential imaging agent technetium oxo complexes, were synthesized.

264 Autoradiography was performed using technetium-pertechnetate and gamma-scintigraphy to asses

265 itute typical anionic, cationic, and neutral technetium radiopharmaceutical kits.

266 een investigated at high pH to determine the technetium retention mechanism(s) on formation and oxida

267 (D) chelates capable of binding M(CO)3+ (M = technetium, rhenium) was conjugated to lisinopril by acy

268 the chelation of 111In, 90Y, or 177Lu, or a technetium/rhenium chelate.

269 The results of thallium/technetium scintigraphy were negative in three patients

270 ardiography and myocardial scintigraphy with technetium sestamibi (MIBI) and meta-[(123)I]iodobenzylg

271 ic solution was developed to convert reduced technetium species to pertechnetate in samples with high

272 A total of 97 patients underwent technetium stress testing (technetium-stress), treadmill

273 T (4.53) than either treadmill-ECG (1.72) or technetium-stress (1.96).

274 gnostic ability than either treadmill-ECG or technetium-stress for the detection of obstructive angio

275 atients underwent technetium stress testing (technetium-stress), treadmill-ECG, and EBCT coronary sca

276 orth Carolina, using a combined blue dye and technetium sulfur colloid technique.

277 88BV59, labeled with technetium Tc 99m (99mTc) (HumaSPECT-Tc), was injected i

278 Leakage was assessed with technetium Tc 99m radiolabeled human serum albumin, and

279 with thallous chloride TI 201 (thallium) or technetium Tc 99m sestamibi for detection and/or evaluat

280 We demonstrated colocalization between technetium Tc 99m tilmanocept (99mTc-tilmanocept) and CD

281 Pelvic/systemic ratios of melphalan/TNF/technetium Tc 99m were 14.2/7/3.6.

282 Because of the worldwide shortage of technetium Tc 99m, physicians are looking for nonradioac

283 Detection of a technetium Tc 99m-marked SLN before surgery was possible

284 reen is considered a possible alternative to technetium Tc 99m.

285 node is preoperative lymphoscintigraphy with technetium Tc 99m.

286 with SLNE using standard technique guided by technetium Tc 99m.

287 lized through site-specific rhenium (Re) and technetium (Tc) metal coordination, were structurally ch

288 Technetium (Tc) remains a priority remediation concern d

289 IIa platelet inhibitor DMP-444, labeled with technetium (Tc)-99 m, to identify platelet-rich thrombus

290 liminary reports have demonstrated that (99m)technetium (Tc)-labeled cyclic [Cys(3,4,10), D-Phe7]alph

291 travenous infusion of the radioactive tracer Technetium- Tc 99 m Hexamethylpropyleneamine Oxime (Tc-9

292 tomography, magnetic resonance imaging, and technetium thallium scans were 48%/21%, 52%/16%, 48%/14%

293 Technetium tribromide is isomorphous with RuBr(3) and Mo

294 s, 3d (IC(50) = 9 nM), was radiolabeled with technetium tricarbonyl ({(99m)Tc(CO)(3)}(+)) to afford t

295 Technetium, uranium, and neptunium are contaminants that

296 Bis(N-ethoxy,N-ethyldithiocarbamato)nitrido technetium (V) ((99m)Tc) ((99m)TcN-NOET) is a myocardial

297 This ligand complexes technetium(V) in its neutral oxo form.

298 ptoethyl)amino)acetyl)-2-aminoethanethiolato]technetium(V) oxide), a DAT imaging agent that has emerg

299 Technetium was separated from the actinides via valence

300 tical procedure involves preconcentration of technetium with coprecipitation, online separation using